140 related articles for article (PubMed ID: 34302713)
1. Cobalamin deficiency during treatment of pediatric precursor B-cell acute lymphoblastic leukemia.
Kinoshita H; Watanabe A; Taji Y; Yoshimura M; Ohta A; Fukushima T; Tanaka R; Ebihara Y
Pediatr Blood Cancer; 2021 Dec; 68(12):e29258. PubMed ID: 34302713
[No Abstract] [Full Text] [Related]
2. Precursor B-cell acute lymphoblastic leukemia in a pediatric patient with Bainbridge-Ropers syndrome.
Slatnick LR; Angione K; Hartman L
Pediatr Blood Cancer; 2023 Jan; 70(1):e29873. PubMed ID: 35733401
[No Abstract] [Full Text] [Related]
3. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
4. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
[No Abstract] [Full Text] [Related]
5. Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia, who have been treated with Blinatumomab.
Mikhailova E; Gluhanyuk E; Illarionova O; Zerkalenkova E; Kashpor S; Miakova N; Diakonova Y; Olshanskaya Y; Shelikhova L; Novichkova G; Maschan M; Maschan A; Popov A
Haematologica; 2021 Jul; 106(7):2009-2012. PubMed ID: 33375769
[TBL] [Abstract][Full Text] [Related]
6. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
[No Abstract] [Full Text] [Related]
7. Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B-acute lymphoblastic leukaemia.
Collignon C; Domenech C; Ducassou S; Pluchart C; Bruno B; Pasquet M; Simon P; Petit A; Rialland-Battisti F; Brethon B
Br J Haematol; 2023 May; 201(4):e42-e45. PubMed ID: 36971071
[No Abstract] [Full Text] [Related]
8. Generalized leukemia cutis as the initial manifestation of precursor B-cell acute lymphoblastic leukemia in a young male.
Kanoje PK; Khullar G; Yadav AK; Saxena AK; Gupta DK
Dermatol Ther; 2021 Jan; 34(1):e14594. PubMed ID: 33247514
[No Abstract] [Full Text] [Related]
9. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
10. Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia.
Bergeron BP; Barnett KR; Bhattarai KR; Mobley RJ; Hansen BS; Brown A; Kodali K; High AA; Jeha S; Pui CH; Peng J; Pruett-Miller SM; Savic D
Blood Adv; 2023 Aug; 7(15):4107-4111. PubMed ID: 37289547
[No Abstract] [Full Text] [Related]
11. Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia.
Fulcher J; Leung E; Christou G; Bredeson C; Sabloff M
Leuk Lymphoma; 2020 Sep; 61(9):2271-2273. PubMed ID: 32427017
[No Abstract] [Full Text] [Related]
12. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
13. [Optimized treatment of childhood B-lineage acute lymphoblastic leukemia].
Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Apr; 25(4):344-349. PubMed ID: 37073837
[TBL] [Abstract][Full Text] [Related]
14. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognosis of various immunocytological subvariants of acute lymphoblastic leukemia in children].
Klubovskaia NI; Tsveĭbakh AS; Petrova EM; Pustovalova AG; Bessonova AG
Pediatriia; 1989; (2):30-4. PubMed ID: 2726363
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Einsiedel HG; Kawan L; Eckert C; Witt O; Fichtner I; Henze G; Seeger K
Leukemia; 2006 Aug; 20(8):1435-6. PubMed ID: 16810202
[No Abstract] [Full Text] [Related]
17. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Gururangan S; Horner M; Rodman JH; Marina NM
Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
[TBL] [Abstract][Full Text] [Related]
18. [Increased B-lymphocyte prognitor cells in a boy with acute lymphoblastic leukemia after chemotherapy].
Ye QD; Wang X; Miao Y; Pan C; Tang JY
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Sep; 16(9):955-6. PubMed ID: 25229969
[No Abstract] [Full Text] [Related]
19. Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.
Ivanov V; Farnault L; Mercier C; Colavolpe C; Venton G; Colle J; Lepidi H; Arnoux I; Nicolino-Brunet C; Berda-Haddad Y; Fanciullino R; Ivanov G; Costello R
Leuk Lymphoma; 2020 May; 61(5):1230-1233. PubMed ID: 31900013
[No Abstract] [Full Text] [Related]
20. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation.
Dong N; Ma HX; Liu XQ; Li D; Liu LH; Shi Q; Ju XL
Cell Death Dis; 2024 Mar; 15(3):216. PubMed ID: 38485947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
